Camp4 Therapeutics Corp (CAMP) Institutional Ownership

Ownership Summary

The institutional landscape for Camp4 Therapeutics Corp (NASDAQ:CAMP) includes 29 filers as of the latest reporting cycle ending September 2025.

• The percentage of Camp4 Therapeutics owned by institutions changed from 58.3% in June 2025 to 139.9% in September 2025, marking a slight up trend.
• Institutional share ownership changed by 140.92% QoQ, while the number of institutional owners saw an unavailable change YoY.
• Among the 29 institutional holders of Camp4 Therapeutics, 10 added to their stakes while 12 trimmed their positions and 7 held steady.
• The aggregate institutional position in Camp4 Therapeutics now stands at 28.21Mn shares as of September 2025, after investors increased their holdings (up by 16.50Mn shares quarter on quarter which is down N/A shares year over year).
• As of September 30, 2025, 5AM Venture Management, LLC held Camp4 Therapeutics's largest shareholding position with over 5.87Mn shares, representing 29.11% of total outstanding shares.
• Among the most significant buyers of Camp4 Therapeutics during September 2025 were JANUS HENDERSON GROUP PLC (4.64Mn), Vivo Capital, LLC (3.92Mn), 5AM Venture Management, LLC (2.94Mn), FMR LLC (2.42Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.96Mn).
• Leading sellers of Camp4 Therapeutics stock in September 2025 included BlackRock, Inc. (72.78K), MILLENNIUM MANAGEMENT LLC (37.97K), VANGUARD GROUP INC (15.38K), GEODE CAPITAL MANAGEMENT, LLC (14.83K), BARCLAYS PLC (7.44K).
• The top 10 institutional holders of Camp4 Therapeutics for the quarter ending September 2025 included 5AM Venture Management, LLC (5.87Mn), JANUS HENDERSON GROUP PLC (4.64Mn), Vivo Capital, LLC (3.92Mn), Enavate Sciences GP, LLC (3.79Mn), FMR LLC (3.02Mn), a16z Capital Management, L.L.C. (2.13Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.96Mn), HARBOURVEST PARTNERS LLC (1.27Mn), SILVERARC CAPITAL MANAGEMENT, LLC (653.59K), VANGUARD GROUP INC (313.51K).